TNF and rheumatoid arthritis: Specific targeting of immune processes has become possible with biological drugs, some of which have proven to be extremely efficent in controling autoimmune diseases such as anti-TNF-α in rheumatoid arthritis and Crohn’s disease or anti-CD20 in rheumatoid arthritis and ANCA vasculitis.